These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9838309)

  • 1. Donor specific CDC lymphocyte crossmatch and five year allograft survival.
    Sharma RK; Singh AK; Agrawal S; Gupta A; Avula S; Kumar A; Kapoor R; Bhandari M
    Transplant Proc; 1998 Nov; 30(7):2966. PubMed ID: 9838309
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of race, PRA level, and gender on the incidence of a positive donor-specific preliminary T cell crossmatch.
    Bryan CF; Aeder MI; Helling TS; Luger AM; Nelson PW; Pierce GE; Shield CF; Thomas A
    Transplant Proc; 1992 Dec; 24(6):2517-8. PubMed ID: 1465851
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preexisting antibodies: the clinical relevance of auto-B-lymphocyte antibody and positive B-cell crossmatch.
    Mongkolsuk T; Chiewsilp P; Sujirachato K; Sumethkul V; Jirasiritham S; Chalermsanyakorn P; Danviriyasup K
    Transplant Proc; 1996 Jun; 28(3):1215-6. PubMed ID: 8658631
    [No Abstract]   [Full Text] [Related]  

  • 5. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
    Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
    Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant flow cytometry crossmatch in first cadaveric kidney transplants.
    Mascaretti L; Sioli V; Puglisi G; Rossini G; Trezzi D; Scarpino C; Scalamogna M; Sirchia G
    Transplant Proc; 1995 Feb; 27(1):668-70. PubMed ID: 7879138
    [No Abstract]   [Full Text] [Related]  

  • 9. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
    ten Hoor GM; Coopmans M; Allebes WA
    Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotypic autoantibodies after donor-specific blood transfusions.
    Toma H; Hayasaka Y; Yasuo M; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1987 Feb; 19(1 Pt 1):755-7. PubMed ID: 3274864
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of anti-idiotypic antibodies in sensitized patients awaiting renal transplantation.
    Ramounau-Pigot A; Mourad G; Cristol JP; Argiles A; Seignalet J
    Transplant Proc; 1992 Dec; 24(6):2496. PubMed ID: 1465843
    [No Abstract]   [Full Text] [Related]  

  • 12. Transplantation with positive complement-dependent microcytotoxicity crossmatch in contemporary kidney transplantation: Practice patterns and associated outcomes.
    Graff RJ; Xiao H; Duffy B; Schnitzler MA; Axelrod D; Lentine KL
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):234-45. PubMed ID: 22382213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival.
    Christiaans MH; Overhof-de Roos R; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 1998 Feb; 65(3):427-33. PubMed ID: 9484765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients.
    Lorenz M; Regele H; Schillinger M; Kletzmayr J; Haidbauer B; Derfler K; Druml W; Böhmig GA
    Transplantation; 2005 Mar; 79(6):696-701. PubMed ID: 15785376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of kidney transplantation in preformed antibody-positive highly sensitized recipients.
    Harano M; Tanabe K; Tokumoto T; Ishikawa N; Shimizu T; Shimmura H; Yagisawa T; Fuchinoue S; Nakajima I; Toma H; Agishi T
    Transplant Proc; 1999 Nov; 31(7):2863-6. PubMed ID: 10578317
    [No Abstract]   [Full Text] [Related]  

  • 17. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
    Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting long-term renal allograft survival in cyclosporine-treated kidney transplants.
    Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Oshima T; Fuchinoue S; Toma H
    Transplant Proc; 1998 Aug; 30(5):1805-9. PubMed ID: 9723291
    [No Abstract]   [Full Text] [Related]  

  • 20. Recipient HLA-DR phenotypes influence survival of living-related donor renal allografts.
    Endo T; Watanabe K; Uchida H; Endo T; Okubo M; Kashiwagi N
    Transplant Proc; 1987 Feb; 19(1 Pt 1):696-8. PubMed ID: 3274846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.